deaths from tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Tirzepatide (Zepbound) for weight loss

We are proud to have helped numerous individuals achieve significant and lasting weight loss through our Semaglutide treatment programs

Continuation of GLP-1 Receptor Agonist Use in Early Pregnancy Seems Safe WEDNESDAY, June 10, 2026 -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associated with the risk for nonlive birth, abnormal fetal growth, or major congenital malformation (MCM), according to a study published online June 9 in the Annals of Internal Medicine

Compounded Semaglutide can also be adjusted to each patient it is prescribed to, offering better flexibility

Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG

Pancreatitis and diabetic retinopathy were less common, suggesting semaglutide's benefits in managing type 2 diabetes extend to substantial weight loss and blood pressure improvement, with a need for further safety monitoring

In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium-glucose cotransporter 2 (SGLT2) inhibitors compared to patients who received placebo